John M. Kane

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.926Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Early Intervention in Psychiatry(2023)10.1111/eip.13457

Top 33%

0.607DataRank

Top 33%41 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +68 more

Papers

Driven by 35 papers — median percentile 29. Top paper: “What is the duration of untreated psychosis worldwide? – A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies”.

What is the duration of untreated psychosis worldwide? – A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies

Psychological Medicine(2023)10.1017/s0033291723003458

N/A

0.609DataRank · unranked

57 citations

Clàudia Aymerich, Daniel Guinart, Ana Catalán, Luis Alameda, Giulia Trotta +11 more

Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Early Intervention in Psychiatry(2023)10.1111/eip.13457

Top 33%

0.607DataRank

Top 33%41 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +68 more

Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00572-7

N/A

0.241DataRank · unranked

4 citations

Beier Yao, Lisa Brown, S. Sánchez García, Arundati Nagendra, Kota Chin +40 more

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00561-w

Top 63%

0.215DataRank

Top 63%3 citations

Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah +58 more

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open(2025)10.1093/schizbullopen/sgaf013

Top 78%

0.104DataRank

Top 78%1 citations

Amy Shalev, Lu Liu, Cari Jahraus, Monica Chu, Emily K. Farina +75 more

The Reintegration Journey Following a Psychiatric Hospitalization: Examining the Role of Social Technologies

Proceedings of the ACM on Human-Computer Interaction(2022)10.1145/3512969

N/A

0DataRank · unranked

14 citations

Jordyn Seybolt, Dong Whi Yoo, Michael L. Birnbaum, John M. Kane, Munmun De Choudhury +1 more

Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization

Frontiers in Medicine(2022)10.3389/fmed.2022.841326

N/A

0DataRank · unranked

9 citations

Alexander Makhnevich, Wentian Li, Yan Liu, Michael Qiu, Allison Marziliano +8 more

Impact-Tardive Dyskinesia (Impact-TD) Scale

The Journal of Clinical Psychiatry(2022)10.4088/jcp.22cs14563

N/A

0DataRank · unranked

9 citations

Matthew Brams, Noelle E. Carlozzi, Leslie Citrome, Nora E. Fritz, A. Robelo Hoberg +4 more

The place of long-acting injectable antipsychotics in the treatment of schizophrenia

Therapeutic Advances in Psychopharmacology(2023)10.1177/20451253231157219

N/A

0DataRank · unranked

11 citations

José M. Rubio, John M. Kane

The use of long-acting injectables in early-phase schizophrenia

The Lancet Psychiatry(2023)10.1016/s2215-0366(23)00069-x

N/A

0DataRank · unranked

5 citations

Taishiro Kishimoto, Eric D. Achtyes, José M. Rubio, Christoph U. Correll, John M. Kane

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

medRxiv(2023)10.1101/2023.04.29.23289226

N/A

0DataRank · unranked

21 citations

Sophie Parker, Melissa Kerr, Barbara C. Walsh, S. Andrea Wijtenburg, Nicholas Prunier +83 more

Replication of a neuroimaging biomarker for striatal dysfunction in psychosis

medRxiv(2023)10.1101/2023.07.17.23292779

N/A

0DataRank · unranked

2 citations

Todd Lencz, Hengyi Cao, Nina V. Kraguljac, Elvisha Dhamala, Philipp Homan +9 more

Replication of a neuroimaging biomarker for striatal dysfunction in psychosis

Research Square(2023)10.21203/rs.3.rs-3185688/v1

N/A

0DataRank · unranked

0 citations

Todd Lencz, Hengyi Cao, Nina V. Kraguljac, Elvisha Dhamala, Philipp Homan +9 more

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Schizophrenia Bulletin(2024)10.1093/schbul/sbae011

N/A

0DataRank · unranked

75 citations

Barnaby Nelson, Jean Addington, Kelly Allott, Alan Anticevic, Celso Arango +95 more

Replication of a neuroimaging biomarker for striatal dysfunction in psychosis

Molecular Psychiatry(2024)10.1038/s41380-023-02381-9

N/A

0DataRank · unranked

13 citations

Todd Lencz, Hengyi Cao, Nina V. Kraguljac, Elvisha Dhamala, Philipp Homan +9 more

Automated, Objective Speech and Language Markers of Longitudinal Changes in Psychosis Symptoms

medRxiv(2024)10.1101/2024.07.19.24310718

N/A

0DataRank · unranked

2 citations

Michael J. Spilka, Majnu John, Michael L. Birnbaum, Ema Saito, Sarah Berretta +6 more

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

UNC Libraries(2024)10.17615/rqtf-zj40

N/A

0DataRank · unranked

0 citations

Kerstin Langbein, Andrew Thompson, Louise Birkedal Glenthøj, César Salinas, Patrick D. McGorry +95 more

Automated speech and language markers of longitudinal changes in psychosis symptoms

NPP—Digital Psychiatry and Neuroscience(2025)10.1038/s44277-025-00034-z

N/A

0DataRank · unranked

13 citations

Michael J. Spilka, Majnu John, Michael L. Birnbaum, Ema Saito, Sarah Berretta +6 more

Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00599-w

N/A

0DataRank · unranked

10 citations

Ann Ee Ching, Yoonho Chung, Habiballah Rahimi-Eichi, Erlend Lane, Carsten Langholm +75 more

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Schizophrenia(2025)10.1038/s41537-025-00578-1

N/A

0DataRank · unranked

8 citations

Walid Yassin, Luis Alameda, Tashrif Billah, Owen Borders, Kate Buccilli +93 more

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00581-6

N/A

0DataRank · unranked

8 citations

Kang Ik K. Cho, Alan Anticevic, Nicolas R. Bolo, Sylvain Bouix, Dylan Campbell +82 more

Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00560-x

N/A

0DataRank · unranked

8 citations

Kang Ik K. Cho, Owen Borders, Yoonho Chung, Michaela Ennis, Grace R. Jacobs +63 more

Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations

Schizophrenia(2025)10.1038/s41537-025-00610-4

N/A

0DataRank · unranked

8 citations

Clark Jeffries, Scott R. Clark, Rachel Upthegrove, Cassandra Wannan, Naomi R. Wray +35 more

Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for Psychosis

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.25644

N/A

0DataRank · unranked

3 citations

Grace R. Jacobs, Jenna Reinen, Daniel H. Mathalon, Cheryl M. Corcoran, Abraham Reichenberg +19 more

Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

Schizophrenia(2025)10.1038/s41537-025-00669-z

N/A

0DataRank · unranked

2 citations

Eduardo Castro, Carla Agurto, Einat Liebenthal, Michaela Ennis, Justin T. Baker +72 more

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001987

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001990

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more

Computational speech markers of negative symptoms show evidence of being robust to antipsychotic dose and extrapyramidal symptoms in schizophrenia

(2025)10.31234/osf.io/zgvyt_v2

N/A

0DataRank · unranked

1 citations

Jessica Robin, Amir Hossein Nikzad, Leily Behbehani, Sarah Berretta, Mengdan Xu +4 more

Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open(2025)10.1093/schizbullopen/sgaf012

Top 100%

0DataRank

Top 100%0 citations

Lu Liu, Monica Chu, Karl Jungert, Nora Penzel, Ofer Pasternak +77 more

Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia

American Journal of Psychiatry(2020)10.1176/appi.ajp.2019.19030324

N/A

0DataRank · unranked

67 citations

Laura J. Fochtmann, Greg Perlman, Yuan Tian, John M. Kane, Evelyn J. Bromet +2 more

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

UNC Libraries(2025)10.17615/2934-4s70

N/A

0DataRank · unranked

0 citations

Sylvain Bouix, Michael J. Coleman, Catalina Mourgues, Beau‐Luke Colton, Merete Nordentoft +68 more

The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components

UNC Libraries(2020)10.17615/nnjc-rk05

N/A

0DataRank · unranked

0 citations

Shirley M. Glynn, Mary F. Brunette, Sylvia Saade, Robert A. Rosenheck, David Lynde +11 more

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

UNC Libraries(2020)10.17615/rsa5-5c73

N/A

0DataRank · unranked

0 citations

Alexander L. Miller, Majnu John, Benji T. Kurian, Jean Addington, Robert Heinssen +21 more

Utilizing Instagram Data to Identify Usage Patterns Associated With Schizophrenia Spectrum Disorders

Frontiers in Psychiatry(2021)10.3389/fpsyt.2021.691327

N/A

0DataRank · unranked

21 citations

Inna Wanyin Lin, Michael Sobolev, Whitney Muscat, Sabrina Yum-Chan, Munmun De Choudhury +3 more

A Social Media Study on Mental Health Status Transitions Surrounding Psychiatric Hospitalizations

Proceedings of the ACM on Human-Computer Interaction(2021)10.1145/3449229

N/A

0DataRank · unranked

19 citations

Kathan H. Kashiparekh, Amir Bolous, Asra Ali, John M. Kane, Michael L. Birnbaum +2 more

John M. Kane

Indexed papers

Top data-sharing exemplar

Papers